These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18697284)

  • 1. The Canadian lipid guidelines are difficult to model quantitatively.
    Holmes DT; Frohlich JJ
    Can J Cardiol; 2008 Aug; 24(8):621. PubMed ID: 18697284
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporating the new lipid guidelines into practice.
    Spear S
    JAAPA; 2014 Jun; 27(6):11. PubMed ID: 24803202
    [No Abstract]   [Full Text] [Related]  

  • 3. The 2006 Canadian dyslipidemia guidelines will prevent more deaths while treating fewer people--but should they be further modified?
    Manuel DG; Wilson S; Maaten S
    Can J Cardiol; 2008 Aug; 24(8):617-20. PubMed ID: 18685741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Artery Calcium and Shared Decision Making.
    Hecht HS; Shaw LJ; Chandrashekhar Y; Narula J
    JACC Cardiovasc Imaging; 2016 May; 9(5):637-9. PubMed ID: 27151526
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of statins on atherosclerotic plaque.
    Almeida SO; Budoff M
    Trends Cardiovasc Med; 2019 Nov; 29(8):451-455. PubMed ID: 30642643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Statin Use With Cardiovascular Outcomes by Coronary Calcium: MESA.
    Zhou Z; Ong KL; Breslin M; Allison MA; Curtis AJ; Nelson MR
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):1094-1096. PubMed ID: 31928940
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL.
    Shah PK
    Curr Opin Cardiol; 2010 Nov; 25(6):603-8. PubMed ID: 20827180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
    Robinson JG
    Future Cardiol; 2014 Mar; 10(2):149-52. PubMed ID: 24762237
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacotherapy of dyslipidemias in the adult population.
    Vigna GB; Fellin R
    Expert Opin Pharmacother; 2010 Dec; 11(18):3041-52. PubMed ID: 20958118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia.
    Oesterle A; Liao JK
    Curr Vasc Pharmacol; 2019; 17(3):222-232. PubMed ID: 30124154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motivational effects of coronary artery calcium scores on statin adherence and weight loss.
    Kalia NK; Cespedes L; Youssef G; Li D; Budoff MJ
    Coron Artery Dis; 2015 May; 26(3):225-30. PubMed ID: 25514570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy men should not take statins.
    Redberg RF; Katz MH
    JAMA; 2012 Apr; 307(14):1491-2. PubMed ID: 22496261
    [No Abstract]   [Full Text] [Related]  

  • 14. Statin therapy for healthy men identified as "increased risk".
    Blaha MJ; Nasir K; Blumenthal RS
    JAMA; 2012 Apr; 307(14):1489-90. PubMed ID: 22496260
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins and the soul of medicine.
    Ornish D
    Am J Cardiol; 2002 Jun; 89(11):1286-90. PubMed ID: 12031729
    [No Abstract]   [Full Text] [Related]  

  • 16. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
    [No Abstract]   [Full Text] [Related]  

  • 20. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.